These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30332412)

  • 1. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
    Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
    PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of compound kill kinetics against Mycobacterium tuberculosis.
    Early J; Alling T
    Methods Mol Biol; 2015; 1285():269-79. PubMed ID: 25779322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antitubercular activity of ferrocene-based hydrazones.
    Mahajan A; Kremer L; Louw S; Guérardel Y; Chibale K; Biot C
    Bioorg Med Chem Lett; 2011 May; 21(10):2866-8. PubMed ID: 21507641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
    Early JV; Mullen S; Parish T
    PLoS One; 2019; 14(10):e0222970. PubMed ID: 31589621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
    Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
    Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrazones as a privileged structural linker in antitubercular agents: a review.
    Mathew B; Suresh J; Ahsan MJ; Mathew GE; Usman D; Subramanyan PN; Safna KF; Maddela S
    Infect Disord Drug Targets; 2015; 15(2):76-88. PubMed ID: 26205803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-tubercular evaluation of 4-quinolylhydrazones.
    Savini L; Chiasserini L; Gaeta A; Pellerano C
    Bioorg Med Chem; 2002 Jul; 10(7):2193-8. PubMed ID: 11983516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
    Flint L; Korkegian A; Parish T
    PLoS One; 2020; 15(11):e0239354. PubMed ID: 33201882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
    Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
    Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitubercular activity of new L-serinyl hydrazone derivatives.
    Pinheiro AC; Kaiser CR; Nogueira TC; Carvalho SA; da Silva EF; Feitosa Lde O; Henriques Md; Candéa AL; Lourenço MC; de Souza MV
    Med Chem; 2011 Nov; 7(6):611-23. PubMed ID: 22313301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Spectroscopic, In-vitro and Computational Analysis of Hydrazones as Potential Antituberculosis Agents: (Part-I).
    Thorat BR; Rani D; Yamgar RS; Mali SN
    Comb Chem High Throughput Screen; 2020; 23(5):392-401. PubMed ID: 32209038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.
    Odingo JO; Early JV; Smith J; Johnson J; Bailey MA; Files M; Guzman J; Ollinger J; Korkegian A; Kumar A; Ovechkina Y; Parish T
    Drug Dev Res; 2019 Aug; 80(5):566-572. PubMed ID: 30893501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
    Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
    Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones.
    Koçyiğit KB; Rollas S
    Farmaco; 2002 Jul; 57(7):595-9. PubMed ID: 12164221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New fluorine-containing hydrazones active against MDR-tuberculosis.
    Vavříková E; Polanc S; Kočevar M; Horváti K; Bosze S; Stolaříková J; Vávrová K; Vinšová J
    Eur J Med Chem; 2011 Oct; 46(10):4937-45. PubMed ID: 21855181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antituberculosis activity of indole-pyridine derived hydrazides, hydrazide-hydrazones, and thiosemicarbazones.
    Velezheva V; Brennan P; Ivanov P; Kornienko A; Lyubimov S; Kazarian K; Nikonenko B; Majorov K; Apt A
    Bioorg Med Chem Lett; 2016 Feb; 26(3):978-985. PubMed ID: 26725953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitubercular activity of new coumarins.
    Cardoso SH; Barreto MB; Lourenço MC; Henriques Md; Candéa AL; Kaiser CR; de Souza MV
    Chem Biol Drug Des; 2011 Jun; 77(6):489-93. PubMed ID: 21414146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
    Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of pyrrole hydrazones as new anti-tuberculosis agents.
    Lessigiarska I; Pajeva I; Prodanova P; Georgieva M; Bijev A
    Med Chem; 2012 May; 8(3):462-73. PubMed ID: 22530903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.